Publicaciones en las que colabora con PABLO AVANZAS FERNANDEZ (11)

2021

  1. Efecto de la pandemia por COVID-19 en la formación de los residentes de cardiología: más allá del efecto clínico

    Archivos de cardiologia de Mexico, Vol. 91, pp. 18-24

  2. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

2020

  1. Characterization of left ventricular non-compaction cardiomyopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-16

  2. Clinical implications and gender differences of kcnq1 p.Gly168arg pathogenic variant in long qt syndrome

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-12

2013

  1. Real incidence of diabetes mellitus in a coronary disease population

    American Journal of Cardiology, Vol. 111, Núm. 3, pp. 333-338

2011

  1. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H

    Mitochondrion, Vol. 11, Núm. 1, pp. 176-181

  2. Rendimiento de la glucohemoglobina y un modelo de riesgo para la detección de diabetes desconocida en pacientes coronarios

    Revista Espanola de Cardiologia, Vol. 64, Núm. 9, pp. 759-765

2010

  1. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial

    Circulation, Vol. 121, Núm. 10, pp. 1176-1187

2009

  1. Lack of association between endothelin-1 gene variants and myocardial infarction

    Journal of Atherosclerosis and Thrombosis, Vol. 16, Núm. 4, pp. 388-395

  2. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: A case-control study in a Spanish population

    Coronary Artery Disease, Vol. 20, Núm. 6, pp. 383-386

  3. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention

    European Heart Journal, Vol. 30, Núm. 21, pp. 2614-2621